US · Healthcare

Entia Biosciences Inc (ERGO)

Biotechnology

Entia Biosciences Inc (ERGO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ERGO

P/E ratio

25.00

Entia Biosciences Inc (ERGO) — FAQ

What is ERGO's P/E ratio?

The price-to-earnings (P/E) ratio for Entia Biosciences Inc (ERGO) is 25.00 (data as of 2026-05-23).

Does Entia Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Entia Biosciences Inc (ERGO). Check the MyAverix Finance app for the latest dividend data.

What sector is Entia Biosciences Inc in?

Entia Biosciences Inc (ERGO) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ERGO listed on?

ERGO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)